FILE:STJ/STJ-8K-20040817170547.txt.gz
EVENTS:	Regulation FD Disclosure
TEXT:
ITEM: Regulation FD Disclosure
UNITED STATES
Item 9.  
Regulation FD Disclosure
On August 16, 2004, the registrant issued a press release concerning a share repurchase program of up to $300 million of its outstanding common stock; a copy of which is furnished herewith as Exhibit 1.
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ST. JUDE MEDICAL, INC.
Date:  
August 17, 2004
By:
/s/   Kevin T. O'Malley            
Kevin T. O'Malley
Vice President and
General Counsel
                                                        EXHIBIT INDEX
                                           
Exhibit
Description of Exhibit
    1                                                 Press Release, dated August 16, 2004

Exhibit 1
St. Paul, MN, August 16, 2004  St. Jude Medical, Inc. (NYSE:STJ) announced today that its Board of Directors has authorized a share repurchase program of up to $300 million of its outstanding common stock. The authorization expires on December 31, 2006. The repurchases will occur at such times and at such prices as the management of the Company determines and may be effected through transactions in the open market, in privately negotiated transactions or in derivative transactions. The share repurchase program will be funded by the Company's existing commercial paper program.
St. Jude Medical, Inc. () is dedicated to the design, manufacture and distribution of innovative medical devices of the highest quality, offering physicians, patients and payers unmatched clinical performance and demonstrated economic value.
www.sjm.com


